Study Stopped
Ran out of funding
Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin
SMARTevans
1 other identifier
observational
11
1 country
1
Brief Summary
This research study aims to determine if there are differences in oxygen consumption between chronically sun exposed and less sun exposed skin. This study uses a new imaging device that can detection oxygenation properties skin in a non-invasive manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2017
CompletedFirst Submitted
Initial submission to the registry
October 5, 2017
CompletedFirst Posted
Study publicly available on registry
October 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2019
CompletedAugust 14, 2019
August 1, 2019
1.9 years
October 5, 2017
August 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Differences in the relative (sun exposed vs nonexposed) and absolute oxygen properties within an individual and between the two age groups
The skin's partial pressure of oxygen and oxygen consumption rate is measured at 4 different locations on the subjects arms using the oxygen sensing device, where it is expected that that difference between more sun exposed regions and less sun exposed regions will be greater in the population of older adults.
20 min estimated per subject
Secondary Outcomes (1)
The differences in the relative (sun exposed vs nonexposed) and absolute oxygen properties between the sexes
20 min estimated per subject
Other Outcomes (1)
The oxygen properties connected to lifestyle choices, such as sun-seeking behavior, lifetime sun exposure levels, and smoking.
20 min estimated per subject, plus time to fill in questionnaire response
Study Arms (4)
Younger Women
Women ages 20-30 who are not pregnant will be painted with oxygen sensing bandage
Younger Men
Men ages 20-30 will be painted with oxygen sensing bandage
Older Women
Women ages 55-65 who are not pregnant will be painted with oxygen sensing bandage
Older Men
Men ages 55-65 will be painted with oxygen sensing bandage
Interventions
Oxygenation properties will be measured using a transparent paint-on bandage formulation that consists of New-Skin liquid bandage, an oxygen-sensing metallo-porphyrin exhibiting bright red phosphorescence, and the green-fluorescing reference dye fluorescein.
Eligibility Criteria
The study is designed to gather data from two different age groups of men and women to evaluate the differences in skin oxygen properties, if any, between chronically sun exposed and less sun exposed skin. This study makes use of an oxygen sensing bandage device that can quantitatively measure both tissue oxygen partial pressure and oxygen consumption rate. Due to its early stage in development, the device has not yet been designed to control for high melanin content of skin. Thus only subjects with lower melanin content (i.e. Fitzpatrick skin types I - IV) will be included in the study. In addition, tattoo markings, scarring or significant natural discolorations can interfere with the imaging results by absorbing blue light and subjects with any of these will be excluded.
You may qualify if:
- Male or female
- Age groups: 20 - 30 and 55 - 65
- Fitzpatrick skin types I, II, III, and IV
You may not qualify if:
- Fitzpatrick skin types V and above
- Tattoo markings anywhere on the arm(s)
- Significant scarring or discoloration (e.g. birthmarks) on the arm(s)
- Any current injuries, infections or wounds on the arm(s)
- Routinely (4+ doses per week) take high dosages of anti-inflammatory drugs (e.g. aspirin, ibuprofen, corticosteroids), immunosuppressive drugs, or antihistamine medications. However steroid nose drops and/or eye drops are permitted.
- Has taken an anti-inflammatory drug (e.g. aspirin) within the prior 24 hours of the study visit.
- Have diabetes that is treated with injectable or oral insulin
- Have any other active or chronic skin problems on the arms
- Are currently participating in another skin care product study at this or any other facility
- Have participated in any type of skin product treatment study within the past 2 weeks
- Have or ever have had dermatographia
- Pregnant women
- Lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Procter and Gamblecollaborator
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (2)
Koolen PGL, Li Z, Roussakis E, Paul MA, Ibrahim AMS, Matyal R, Huang T, Evans CL, Lin SJ. Oxygen-Sensing Paint-On Bandage: Calibration of a Novel Approach in Tissue Perfusion Assessment. Plast Reconstr Surg. 2017 Jul;140(1):89-96. doi: 10.1097/PRS.0000000000003421.
PMID: 28654595BACKGROUNDRoussakis E, Li Z, Nowell NH, Nichols AJ, Evans CL. Bright, "Clickable" Porphyrins for the Visualization of Oxygenation under Ambient Light. Angew Chem Int Ed Engl. 2015 Dec 1;54(49):14728-31. doi: 10.1002/anie.201506847. Epub 2015 Oct 29.
PMID: 26510549BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Conor L Evans, PhD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 5, 2017
First Posted
October 17, 2017
Study Start
July 17, 2017
Primary Completion
June 6, 2019
Study Completion
June 6, 2019
Last Updated
August 14, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- As collected; until the study is complete and the results and published.
- Access Criteria
- Image data files and subject questionnaires may be used after the study for future research. However, no individually identifiable patient information will be correlated with or otherwise used with the study data. Specimens and data will not be stored at collaborating sites outside of Partners Healthcare.
This study was funded by a research gift from Procter \& Gamble. While the investigator is under no obligation to do so, research results and/or study data may be shared with the company for purposes of future scientific publications and/or research collaborations. However, information shared with the company will not include any identifiers that could be used to link data to individual subjects.